|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 卢比替丁>> 市场分析报告 |
卢比替丁市场分析报告 |
|
Small Cell Lung Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Immunotherapy, Targeted Therapy, Chemotherapy), By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate side, Pembrolizumab), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F ... Market, By Drug Type: Atezolizumab Topotecan Lurbinectedin Durvalumab Methotrexate side Pembrolizumab Small ... Malignant Pleural Mesothelioma- Pipeline Insight, 2022 ... as part of a combination therapy. Lurbinectedin: PharmaMar Lurbinectedin, also known as PM01183, or ... different to its parent compounds. Lurbinectedin inhibits active transcription of ... Products Pegargiminase Pembrolizumab YS110 Lurbinectedin NGR-LTNF MTG201 ... Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022 Report Scope: This report will provide a detailed overview of ovarian cancer, highlighting treatment guidelines with information on the current and potential global market for ovarian cancer and treatments and testing technologies with detailed analysis ... Small Cell Lung Cancer Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030 ... with the introduction of drugs like lurbinectedin. Lurbinectedin targets DNA strands within cancer ... Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review ... Global Oncology Market Outlook to 2027 ... for lung cancer patients (pralsetinib, lurbinectedin, selpercatinib, lapatinib). Besides, FDA approved ... Ewing’s Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major ewing’s sarcoma markets reached a value of US$ 47.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 74.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.1% during 2024-2034. The Ewing’s sarcoma market has been ... Malignant Pleural Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major malignant pleural mesothelioma markets reached a value of US$ 318.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 632.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.45% during 2024-2034. The malignant ... Small Cell Lung Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major small cell lung cancer markets reached a value of US$ 8.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8% during 2024-2034. The small cell lung cancer market ... Pharma Mar SA (PHM) - Financial and Strategic SWOT Analysis Review ... treatment of multiple myeloma; and Zepzelca (lurbinectedin) for small cell lung cancer ... |